ArticleThrombosis journal2021

Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis.

Xiehui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.